Endonovo Therapeutics, Inc. (OTCMKTS:ENDV – Get Free Report)’s stock price crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.00 and traded as high as $0.00. Endonovo Therapeutics shares last traded at $0.00, with a volume of 900,000 shares.
Endonovo Therapeutics Price Performance
Endonovo Therapeutics Company Profile
Endonovo Therapeutics, Inc, a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema.
Further Reading
- Five stocks we like better than Endonovo Therapeutics
- Stock Average Calculator
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- The 3 Best Fintech Stocks to Buy Now
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
Receive News & Ratings for Endonovo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endonovo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
